跳至主要内容
临床试验/KCT0005513
KCT0005513进行中(未招募)未知

Effect of hormone replacement therapy versus risedronate on fractures recurrence after hip fracture surgery in postmenopausal Korean women: a randomized, open-label trial

Samsung Medical Center0 个研究点目标入组 300 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
55(Year) 至 o Limit(—)
性别
Female

入选标准

  • Postmenopausal women (duration of amenorrhea: 12 months or longer or serum follicle-stimulating hormone value: 30 mIU/mL or higher)
  • Acute, first-time, lower-energy trauma hip (femur neck or trochanteric) fracture

排除标准

  • Induced menopause due to chemotherapy or radiation
  • Breast cancer
  • Chronic kidney disease
  • Hepatic failure
  • Major abnormalities detected in routine laboratory tests
  • Life expectancy of less than 6 months.

研究者

相似试验